Liraglutide CAS: 204656-20-2 High quality products. 99% white powder, factory price

• Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates secretion.

  Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.

• 
  

• 
• 
• Liraglutide improves control of blood glucose. It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.
  In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes:
• It acts in a glucose-dependent manner, meaning it will stimulate secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia.
  It has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
  It decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride.
  It lowers blood triglyceride levels.
• 
  

• Packing:                                                              

    5mg/vial 10vials/box

• 10mg/vial 10vials/box

  15mg/vial 10vials/box

  20mg/vial 10vials/box

  30mg/vial 10vials/box

  
  

• • 
  • 
    
• Product Specification:                                                          
• 
  

• Items	Liraglutide
  CAS	204656-20-2
  Molecular Formula	C172H265N43O51
  MW	3751.202
  Melting Point	>182°C (dec.)
  Shelf Life	2 Years When Properly Stored
  Appearance	White Powder
  Packaging	10mg/vial, 10vials/box
  MOQ	10vials
  Storage	Keep in a cool, dry, dark location in a tightly sealed container or cylinder.

• 
• 

Company Profile：                                                                          

LingMi BioTechnology Co., Ltd is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. With years of experience in the pharmaceutical chemical and biosynthetic industries.It provides compliant, stable and cost-effective core raw materials as well as one-stop CDMO/CMO solutions for global pharmaceutical enterprises and innovative drug R&D institutions.